Briefs

Smith & Nephew Buys Blue Belt Holdings

Smith & Nephew has completed its acquisition of Blue Belt Holdings, which focuses on orthopedic robotics-assisted surgery, for $275 million. Blue Belt manufactures the NAVIO surgical system, which provides robotics-assistance in unicondylar or partial knee replacement surgery using CT-free navigation software, as well as a hand-held robotic bone-shaping device. Smith & Nephew also announced intentions to expand the NAVIO platform into total knee, bi-cruciate retaining knee and revision knee implants.

Health Canada Blesses FebriDx Test

Health Canada has issued a device license to RPS Diagnostics for its FebriDx test. The diagnostic helps to identify a pathogen-induced immune response to viral or bacterial acute febrile respiratory infection with a fingerstick blood sample. Results are available in 15 minutes, enabling the establishment of an effective patient treatment plan, RPS says. The test detects heightened levels of Myxovirus resistance A, an intracellular protein that increases when an acute viral infection is present. It also simultaneously tests for C-reactive protein, acute-phase protein that elevates in the presence of a bacterial infection.

FDA Clears Modified Duodenoscope

The FDA has blessed Olympus with clearance for its TJF-Q180V duodenoscope with modifications to the device’s design and labeling. Its new design of the elevator channel sealing mechanism looks to create a tighter seal and reduce the potential for leakage of fluids and tissue into the closed elevator channel. The modifications — which aim to help reduce the risk of bacterial infections — come amid several reports of duodenoscopes being linked to the transmission of antibiotic-resistant infections. Olympus says it will implement a corrective action in the U.S. for currently used TJF-Q180V duodenoscopes. The action involves replacing the forceps elevator mechanism with a new forceps elevator design.

AdvaMed Names Barney to Lead RT

Shandi Barney has joined AdvaMed as vice president and sector lead of radiation therapy. The newly created sector will address the regulatory and payment challenges facing this area of medtech innovation, and promote the benefits and value of RT, including radiotherapy, brachytherapy and proton therapy. Barney has in-depth knowledge in the area of radiation therapy, which is providing safe and effective solutions for patients afflicted with devastating conditions, especially cancers.

Boston Scientific Launches Ureteroscope

Boston Scientific has launched its LithoVue single-use digital flexible ureteroscope in the U.S. and Europe. The device is designed for minimally invasive endoscopic procedures to diagnose and treat stones and other conditions of the kidney, ureter and bladder. According to the devicemaker, the ureteroscope brings high-quality digital visualization and seamless navigation for consistent clinical performance. The device also is available in New Zealand.